The way forward: dry powder inhalers should only be switched with physician agreement and patient training.
Assessment of pharmaceutical performance, patient behaviour and clinical outcomes shows that dry powder inhalers cannot be used interchangeably, even if they contain the same active chemical entity. Consequently, there should be no switching of device without the involvement of the physician and appropriate training for the patient.
Price
D
D
Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, UK. d.price@abdn.ac.uk
D000280:Administration, Inhalation; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D006801:Humans; D009330:Nebulizers and Vaporizers; D010353:Patient Education as Topic; D010819:Physician's Role; D011208:Powders
D001993:Bronchodilator Agents; D011208:Powders